Investors burned by President Trump’s trade fight now have to contend with a spending megabill that risks swelling the ...

Bay Area News Group: Live Organ Donations Are Growing In The U.S., California And Bay Area, But So Is The Need Since 2014, more than 500,000 people in the U.S. have donated organs, 200,000 of ...

Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, ...

Regeneron's win at action means the bankrupt firm's popular DNA-testing service can continue — along with a privacy policy ...

Regeneron Pharmaceutical (REGN) is buying 23andMe’s (MEHCQ) genetics business out of bankruptcy for $256 million, aiming to ...

Regeneron announced a plan to acquire genetic testing firm 23andMe through bankruptcy court, including access to personal genetic data. What to know ...

It will acquire genetic data of more than 15 million customers – raising privacy concerns from individuals who had willingly ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.

Me has found a buyer in biotech company Regeneron Pharmaceuticals. If you want your data removed, here are your options.

The fall of 23andMe raises privacy concerns as Regeneron buys its genetic database for $256M after bankruptcy.

What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.